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risk factor per se. We compared the respective values of metabolic syndrome
and its components to predict presence of CHD.
 
Methods:
 
 A case control study was conducted in 2001-2004, including 748
cases (French male patients with a history of CHD) and 810 controls from the
general population. Data on medical history and cardiovascular risk factors
were collected. Two logistic regression models were built to predict the prob-
ability to be a case (to have CHD). The first one considered metabolic syn-
drome as explanatory variable. In the second one, metabolic syndrome was
replaced by its components (high blood pressure or antihypertensive drug use,
waist circumference, high glycemia or hypoglycemic drug use, plasma triglyc-
erides and HDL-cholesterol). Both models were adjusted for age, level of edu-
cation, physical activity, smoking and LDL-cholesterol.  
 
Results:
 
 Participants were aged 45-75 years old, 45.4% of cases and 18.6%
of controls had a metabolic syndrome. The sensitivity and the specificity of the
first model to predict CHD were 81% and 62%, respectively, and the c-sta-
tistic reached 0.79 [95% CI: 0.76-0.80]. In the second model, sensitivity, spec-
ificity and c-statistic were 82%, 67% and 0.85 [0.83-0.86], thus leading to a
better discrimination. Among cases, 5.6% were adequately reclassified by the
second model (0.7% non adequately reclassified). Among controls, 16.3%
were adequately reclassified, without any wrong reclassification. Overall, the
second model led to an improved net reclassification of 4.9% in cases and
16.3% in controls, compared to the first model. 
 
Conclusions:
 
 Using the components of the metabolic syndrome in algo-
rithms to predict presence of CHD is better than using metabolic syndrome as
a whole entity. This result should improve the screening of people who are
likely to suffer from silent CHD. 
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Objective: 
 
To compare vascular risk factor profiles and early outcomes in
all French patients hospitalized for either acute coronary (ACS), or cere-
brovascular syndromes (CVS), or both, between 2005 and 2008.
 
Setting:
 
 All French hospitals.
 
Design
 
: Retrospective analysis.
 
Data sources:
 
 National database called “Hospital Discharge Diagnosis
Records”.
 
Main outcomes measured:
 
 Number and annual rates, vascular risk factors,
and early outcome of hospitalized patients for a unique stay for ACS or CVS
or for both ACV and CVS in a 2-month time window.
 
Results: 
 
Over the 4-year study-period, 1,189,043 patients were hospital-
ized for CVS and/or ACS. Among these, 638,061 (53.7%) had CVS alone,
525,419 (44.3%) had ACS alone, and 24,163 (2%) had both. Patients of the
latter group were older (75.2 ± 12 years), and had a higher prevalence of
hypertension (50.8%), diabetes (26.3%), and atrial fibrillation (23.9%)
(p<0.001). In contrast, the prevalence of obesity (9.6%) and hypercholester-
olemia (25.7%) was greater in ACS only patients. Patients with both CVS and
ACS had a longer length of stay (16.1 days), and were less likely to be dis-
charged to home. These patients also had a higher in-hospital risk of death, in
men and in women (Figure). This risk remained after adjustment for age, sex,
and vascular risk factors compared with patients with either CVS alone
(OR=1.71, 95% CI: 1.66-1.77) or ACS alone (OR=2.95, 95% CI: 2.85-3.05).
 
Conclusion: 
 
Our study conducted in almost 1.2 million hospitalized
patients provides clear evidence that patients with both CVS and ACS have a
high vascular risk profile and a marked excess risk of early death.
 
(Voir schémas page suivante)
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